Biofrontera AG (BFRA) Financials

NASDAQ Currency in USD Disclaimer

$2.67

north_east NA Past Year
Day's range
$2.6
Day's range
$3.1
$40M$40M$30M$30M$20M$20M$10M$10M$0$0-$10M-$10M-$20M-$20MEarning201420142015201520162016201720172018201820192019202020200%0%-100%-100%-200%-200%-300%-300%-400%-400%-500%-500%-600%-600%Profit Margin
Profit Margin
Revenue
Earnings

BFRA Income statement / Annual

Last year (2020), Biofrontera AG's total revenue was $30.35 M, a decrease of 2.94% from the previous year. In 2020, Biofrontera AG's net income was -$13.02 M. See Biofrontera AG,s key income statements, including revenue, expenses, profit, and income.

Period FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013 FY-2012 FY-2011
Period Ended 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013 12/31/2012 12/31/2011
Operating Revenue $30.35 M $31.27 M $21.11 M $12.03 M $6.13 M $4.14 M $3.10 M $3.11 M $3.43 M $515,296.00
Cost of Revenue $3.54 M $4.88 M $4.45 M $1.72 M $1.65 M $1.24 M $1.12 M $1.60 M $1.51 M $444,884.00
Gross Profit $26.81 M $26.39 M $16.66 M $10.31 M $4.48 M $2.90 M $1.98 M $1.51 M $1.92 M $70,412.00
Gross Profit Ratio 0.88 0.84 0.79 0.86 0.73 0.7 0.64 0.49 0.56 0.14
Research and Development Expenses $4.79 M $4.64 M $4.43 M $4.23 M $4.64 M $6.20 M $4.53 M $3.19 M $1.38 M $1.40 M
General & Administrative Expenses $9.15 M $16.28 M $12.96 M $3.10 M $2.85 M $2.76 M $3.12 M $5.46 M $4.09 M $0.00
Selling & Marketing Expenses $20.48 M $28.86 M $17.74 M $16.92 M $8.76 M $4.17 M $3.85 M $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $29.63 M $45.13 M $30.71 M $20.02 M $11.62 M $6.93 M $6.97 M $5.46 M $4.09 M $0.00
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $3.04 M
Operating Expenses $34.42 M $49.77 M $35.13 M $24.24 M $16.26 M $13.13 M $11.51 M $8.65 M $5.48 M $4.44 M
Cost And Expenses $37.96 M $54.64 M $39.59 M $25.96 M $17.91 M $14.37 M $12.62 M $10.25 M $6.98 M $4.89 M
Interest Income $411,000.00 $127,000.00 $24,000.00 $38,000.00 $2,935.14 $9,225.68 $190,294.00 $0.00 $0.00 $0.00
Interest Expense $3.08 M $2.71 M $1.78 M $1.13 M $1.21 M $1.17 M $1.29 M $0.00 $0.00 $0.00
Depreciation & Amortization $5.33 M $3.16 M $754,000.00 $884,000.00 $830,779.00 $811,681.00 $811,005.00 $742,133.00 $643,290.00 $361,821.00
EBITDA -$4.28 M $804,000.00 -$16.73 M -$14.09 M -$8.54 M -$9.22 M -$8.62 M -$7.32 M -$3.46 M -$4.28 M
EBITDA Ratio -0.14 0.03 -0.79 -1.17 -1.39 -2.23 -2.78 -2.35 -1.01 -8.31
Operating Income Ratio -0.25 -0.75 -0.88 -1.16 -1.92 -2.47 -3.08 -2.29 -1.04 -8.49
Total Other Income/Expenses Net -$5.09 M $18.60 M -$791,000.00 -$2.17 M $1.20 M -$972,456.91 -$1.19 M -$928,877.91 -$550,161.46 -$270,092.52
Income Before Tax -$12.70 M -$4.78 M -$19.27 M -$16.10 M -$10.58 M -$11.20 M -$10.72 M -$8.07 M -$4.10 M -$4.64 M
Income Before Tax Ratio -0.42 -0.15 -0.91 -1.34 -1.73 -2.71 -3.46 -2.59 -1.2 -9.01
Income Tax Expense $326,000.00 $2.58 M -$10.39 M -$1.04 M $2.41 M $196,094.00 $95,592.00 -$928,877.91 $15,262.00 -$270,092.52
Net Income -$13.02 M -$7.64 M -$8.88 M -$16.10 M -$10.58 M -$11.20 M -$10.72 M -$8.07 M -$4.12 M -$4.64 M
Net Income Ratio -0.43 -0.24 -0.42 -1.34 -1.73 -2.71 -3.46 -2.59 -1.2 -9.01
EPS -0.47 -0.33 -0.4 -0.78 -0.66 -0.78 -0.8 -0.59 -0.44 -0.69
EPS Diluted -0.47 -0.33 -0.4 -0.78 -0.66 -0.78 -0.8 -0.59 -0.44 -0.69
Weighted Average Shares Out $27.83 M $22.95 M $22.44 M $20.53 M $16.03 M $14.34 M $13.47 M $13.74 M $9.29 M $6.71 M
Weighted Average Shares Out Diluted $27.83 M $22.95 M $22.44 M $20.53 M $16.03 M $14.34 M $13.47 M $13.74 M $9.29 M $6.71 M
Link